Woodley Farra Manion Portfolio Management Inc Vertex Pharmaceuticals Inc Transaction History

Woodley Farra Manion Portfolio Management Inc

$1.83 Billion
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$255.65 - $303.1 $94,590 - $112,147	-370 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$199.77 - $247.81 $34,959 - $43,366	175 Added 89.74%	370 $88,000
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $32,508 - $43,662	195 New	195 $43,000

Others Institutions Holding VRTX

# of Institutions

1,718

Shares Held

226M

Call Options Held

1.21M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$12.6 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$10.8 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.52 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.02 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodley Farra Manion Portfolio Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Woodley Farra Manion Portfolio Management Inc with notifications on news.

Account